Alexion Pharmaceuticals Inc.

NASDAQ:ALXN  
173.54
+0.21 (+0.12%)
Earnings Announcements

Alexion Q1 Non-Gaap Earnings Per Share $3.52

Published: 04/30/2021 12:19 GMT
Alexion Pharmaceuticals Inc. (ALXN) - Alexion Reports First Quarter 2021 Results.
Q1 Non-GAAP Earnings per Share $3.52.
Q1 GAAP Earnings per Share $2.86.
Q1 Revenue Rose 13 Percent to $1.637 Billion.
Astrazeneca Transaction Expected to Close in 3q21.
Revenue is expected to be $1.64 Billion
Adjusted EPS is expected to be $3.32

Next Quarter Revenue Guidance is expected to be $1.7 Billion
Next Quarter EPS Guidance is expected to be $3.37

More details on our Analysts Page.